Top Markets
Coin of the day
Lannett Company, Inc. Lannett Company, Inc.

Lannett Company, Inc.

LCI
Rang in Aktien #35166
Lannett Company, Inc. operates as a U.S.-based pharmaceutical firm dedicated to... Lannett Company, Inc. operates as a U.S.-based pharmaceutical firm dedicated to the comprehensive process of developing, manufacturing, packaging, commercializing, and distributing generic versions of established brand-name drugs. Its extensive product portfolio encompasses a wide array of dosage forms, including solid oral, extended-release, topical, liquid, nasal, ophthalmic, injectable, patch, foam, buccal, sublingual, and suspension preparations. These generic medications address a broad spectrum of therapeutic areas, such as cardiovascular health, central nervous system disorders, endocrinology, gastrointestinal issues, infectious diseases, pain management, respiratory conditions, and mental health. Notable among its offerings are generic versions of critical medications such as Levothyroxine Sodium, Fluphenazine, Posaconazole, Verapamil SR, Methylphenidate, Omeprazole, and Sumatriptan Nasal spray, alongside others like Amphetamine IR tablets and cocaine hydrochloride solution. Lannett serves a broad and diverse client base, encompassing generic pharmaceutical distributors, drug wholesalers, major chain drug retailers, private label distributors, mail-order pharmacies, other pharmaceutical companies, managed care organizations, hospital buying groups, and governmental entities. The company actively engages in strategic partnerships, maintaining supply and development agreements with key collaborators such as Summit Bioscience LLC, HEC Group, Dexcel Pharma, Elite Pharmaceuticals, RivoPharm, and numerous other entities. Founded in 1942, Lannett Company, Inc. maintains its headquarters in Trevose, Pennsylvania.
Aktienkurs
$0.028
Zuletzt synchronisiert: 2023-05-23
Marktkapitalisierung
$4.34M
Veränderung (1 Tag)
40.00%
Veränderung (1 Jahr)
0.00%
Land
US
Handel Lannett Company, Inc. (LCI)

Kategorie

Kursverlauf für Lannett Company, Inc. (LCI)
Höchster Schlusskurs: $0.02 am 2023-05-01

Niedrigster Schlusskurs: $1.65 am 1995-02-01
Kursverlauf der Aktie von Lannett Company, Inc. von 1995 bis 2026
Jährliche Kursentwicklung
Jahr Leistung
2023 -99.21%
2022 -64.97%
2021 -72.87%
2020 -26.40%
2019 77.99%
2018 -81.40%
2017 13.54%
2016 -40.15%
2015 -10.61%
2014 106.54%
2013 1,644.42%
2012 20.33%
2011 -28.01%
2010 -6.37%
2009 114.62%
2008 -16.29%
2007 -49.10%
2006 -10.81%
2005 -20.63%
2004 -45.26%
2003 37.83%
2002 441.55%
2001 445.00%
2000 -41.55%
1999 -22.30%
1998 -50.77%
1997 86.01%
1996 -50.29%
1995 0.00%
Aktienkurs vergleichbarer Unternehmen oder Wettbewerber
Unternehmen Aktienkurs Veränderung 1J% Land
$171.67 -
DE
$161.67 23.26%
DE
$36.61 22.16%
JP
$225.00 37.51%
CH
$21.30 13.79%
IN